PennantPark Floating Rate Capital Ltd., MFS Special Value Trust, Another 8 Companies Have A High Estimated Dividend Yield

(VIANEWS) – PennantPark Floating Rate Capital Ltd. (PFLT), MFS Special Value Trust (MFV), United Bancorp (UBCP) have the highest dividend yield stocks on this list.

Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. PennantPark Floating Rate Capital Ltd. (PFLT) – Dividend Yield: 11.54%

PennantPark Floating Rate Capital Ltd.’s last close was $10.70, 13.22% under its 52-week high of $12.33. Intraday change was -0.83%.

PennantPark Floating Rate Capital Ltd. is a business development company. It seeks to make secondary direct, debt, equity, and loan investments. The fund seeks to invest through floating rate loans in private or thinly traded or small market-cap, public middle market companies. It primarily invests in the United States and to a limited extent non-U.S. companies. The fund typically invests between $2 million and $20 million. The fund also invests in equity securities, such as preferred stock, common stock, warrants or options received in connection with debt investments or through direct investments. It primarily invests between $10 million and $50 million in investments in senior secured loans and mezzanine debt. It seeks to invest in companies not rated by national rating agencies. The companies if rated would be between BB and CCC under the Standard & Poor's system. The fund invests 30% is invested in non-qualifying assets like investments in public companies whose securities are not thinly traded or do not have a market capitalization of less than $250 million, securities of middle-market companies located outside of the United States, high-yield bonds, distressed debt, private equity, securities of public companies that are not thinly traded, and investment companies as defined in the 1940 Act. Under normal conditions, the fund expects atleast 80 percent of its net assets plus any borrowings for investment purposes to be invested in Floating Rate Loans and investments with similar economic characteristics, including cash equivalents invested in money market funds. It expects to represent 65 percent of its portfolio through senior secured loans. In case of floating rate loans, it holds investments for a period of three to ten years.

Earnings Per Share

As for profitability, PennantPark Floating Rate Capital Ltd. has a trailing twelve months EPS of $-0.11.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.35%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 46.6%, now sitting on 132.39M for the twelve trailing months.

Sales Growth

PennantPark Floating Rate Capital Ltd.’s sales growth for the current quarter is 20.2%.

More news about PennantPark Floating Rate Capital Ltd..

2. MFS Special Value Trust (MFV) – Dividend Yield: 11.34%

MFS Special Value Trust’s last close was $3.91, 17.51% under its 52-week high of $4.74. Intraday change was 1.31%.

MFS Special Value Trust is a closed-ended balanced mutual fund launched and managed by Massachusetts Financial Services Company The fund invests in the public equity and fixed income markets of the United States. It primarily invests in value stocks of companies operating across diversified sectors. The fund employs fundamental analysis and a bottom-up stock picking approach to create its portfolio. For the fixed income component of its portfolio, it seeks to invest in U.S. government securities, foreign government securities, mortgage backed and other asset-backed securities of U.S. and foreign issuers, corporate bonds of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries. The fund benchmarks the performance of its equity portfolio against Russell 1000 Value Index and fixed income against Barclays U.S. High-Yield Corporate Bond 2% Issuer Capped, MFS Special Value Trust Blended Index, and JPMorgan Emerging Markets Bond Index Global Index. MFS Special Value Trust was formed on November 30, 1989 and is domiciled in United States.

Earnings Per Share

As for profitability, MFS Special Value Trust has a trailing twelve months EPS of $0.07.

PE Ratio

MFS Special Value Trust has a trailing twelve months price to earnings ratio of 56.59. Meaning, the purchaser of the share is investing $56.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.56%.

Yearly Top and Bottom Value

MFS Special Value Trust’s stock is valued at $3.96 at 03:15 EST, way below its 52-week high of $4.74 and higher than its 52-week low of $3.74.

Volume

Today’s last reported volume for MFS Special Value Trust is 8492 which is 54.83% below its average volume of 18803.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Oct 16, 2023, the estimated forward annual dividend rate is 0.44 and the estimated forward annual dividend yield is 11.34%.

More news about MFS Special Value Trust.

3. United Bancorp (UBCP) – Dividend Yield: 6.27%

United Bancorp’s last close was $10.20, 36.25% below its 52-week high of $16.00. Intraday change was 0.4%.

United Bancorp, Inc. operates as the bank holding company for Unified Bank that provides commercial and retail banking services in Ohio. It accepts demand, savings, and time deposits, as well as grants commercial, commercial and residential real estate, and consumer loans. As of December 31, 2020, the company operated through a network of nineteen banking offices in Athens, Belmont, Carroll, Fairfield, Harrison, Jefferson, and Tuscarawas Counties in Ohio, as well as Marshall and Ohio Counties in West Virginia and the surrounding localities; and a loan production office in Wheeling, West Virginia. United Bancorp, Inc. was founded in 1902 and is headquartered in Martins Ferry, Ohio.

Earnings Per Share

As for profitability, United Bancorp has a trailing twelve months EPS of $1.53.

PE Ratio

United Bancorp has a trailing twelve months price to earnings ratio of 6.57. Meaning, the purchaser of the share is investing $6.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Sep 6, 2023, the estimated forward annual dividend rate is 0.66 and the estimated forward annual dividend yield is 6.27%.

Volume

Today’s last reported volume for United Bancorp is 5382 which is 71.12% above its average volume of 3145.

Moving Average

United Bancorp’s worth is way under its 50-day moving average of $11.36 and way under its 200-day moving average of $12.70.

Yearly Top and Bottom Value

United Bancorp’s stock is valued at $10.05 at 03:15 EST, way under its 52-week high of $16.00 and above its 52-week low of $10.02.

More news about United Bancorp.

4. Civeo Corporation (CVEO) – Dividend Yield: 5.29%

Civeo Corporation’s last close was $18.90, 48.75% under its 52-week high of $36.88. Intraday change was -1.64%.

Civeo Corporation provides hospitality services to the natural resource industry in Canada, Australia, and the United States. The company develops lodges and villages; and mobile accommodations, including modular, skid-mounted accommodation, and central facilities that provide long-term and temporary work force accommodations. It also offers food, housekeeping, and maintenance services, as well as laundry, facility management and maintenance, water and wastewater treatment, power generation, communication systems, security, and logistics services; and camp management services. In addition, the company provides development activities for workforce accommodation facilities, including site selection, permitting, engineering and design, manufacturing management, and site construction services, as well as catering and managed services. It owns and operates 28 lodges and villages with approximately 30,000 rooms; and a fleet of mobile accommodation assets. The company serves oil, mining, engineering, and oilfield and mining service companies. Civeo Corporation is headquartered in Houston, Texas.

Earnings Per Share

As for profitability, Civeo Corporation has a trailing twelve months EPS of $-0.94.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.41%.

More news about Civeo Corporation.

5. Nuveen California Municipal Value Fund (NCA) – Dividend Yield: 4.2%

Nuveen California Municipal Value Fund’s last close was $8.29, 9.4% below its 52-week high of $9.15. Intraday change was 1.45%.

Nuveen California Municipal Value Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California. The fund invests primarily in municipal securities rated Baa/BBB or better. It invests in securities that provide income exempt from federal and California income tax. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the S&P California Municipal Bond Index and the S&P National Municipal Bond Index. Nuveen California Municipal Value Fund was formed on October 7, 1987 and is domiciled in the United States.

Earnings Per Share

As for profitability, Nuveen California Municipal Value Fund has a trailing twelve months EPS of $-0.78.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.08%.

Yearly Top and Bottom Value

Nuveen California Municipal Value Fund’s stock is valued at $8.41 at 03:15 EST, below its 52-week high of $9.15 and above its 52-week low of $8.07.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7%, now sitting on 12.64M for the twelve trailing months.

More news about Nuveen California Municipal Value Fund.

6. Sangamo Therapeutics (SGMO) – Dividend Yield: 3.14%

Sangamo Therapeutics’s last close was $0.54, 88.83% below its 52-week high of $4.80. Intraday change was -7.15%.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.

Earnings Per Share

As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.93%.

Volume

Today’s last reported volume for Sangamo Therapeutics is 1015540 which is 44.61% below its average volume of 1833720.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Sangamo Therapeutics’s EBITDA is -0.95.

Sales Growth

Sangamo Therapeutics’s sales growth is negative 60.9% for the ongoing quarter and negative 65.9% for the next.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 5.9% and 18.8%, respectively.

More news about Sangamo Therapeutics.

7. Radius Health (RDUS) – Dividend Yield: 2.81%

Radius Health’s last close was $26.29, 28.25% under its 52-week high of $36.64. Intraday change was -1.64%.

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

Earnings Per Share

As for profitability, Radius Health has a trailing twelve months EPS of $0.38.

PE Ratio

Radius Health has a trailing twelve months price to earnings ratio of 68.05. Meaning, the purchaser of the share is investing $68.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.21%.

Moving Average

Radius Health’s worth is way below its 50-day moving average of $29.47 and way below its 200-day moving average of $30.89.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jul 13, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.81%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.8%, now sitting on 3.06B for the twelve trailing months.

Yearly Top and Bottom Value

Radius Health’s stock is valued at $25.86 at 03:15 EST, way under its 52-week high of $36.64 and above its 52-week low of $25.71.

More news about Radius Health.

8. Fastenal Company (FAST) – Dividend Yield: 2.43%

Fastenal Company’s last close was $57.61, 5.45% below its 52-week high of $60.93. Intraday change was 0.58%.

Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, Mexico, and internationally. It offers fasteners, and related industrial and construction supplies under the Fastenal name. The company's fastener products include threaded fasteners, bolts, nuts, screws, studs, and related washers, which are used in manufactured products and construction projects, as well as in the maintenance and repair of machines. It also offers miscellaneous supplies and hardware, including pins, machinery keys, concrete anchors, metal framing systems, wire ropes, strut products, rivets, and related accessories. The company serves the manufacturing market comprising original equipment manufacturers; maintenance, repair, and operations customers; and non-residential construction market, which includes general, electrical, plumbing, sheet metal, and road contractors. It also serves farmers, truckers, railroads, mining companies, schools, and retail trades; and oil exploration, production, and refinement companies, as well as federal, state, and local governmental entities. Fastenal Company was founded in 1967 and is headquartered in Winona, Minnesota.

Earnings Per Share

As for profitability, Fastenal Company has a trailing twelve months EPS of $1.98.

PE Ratio

Fastenal Company has a trailing twelve months price to earnings ratio of 29.08. Meaning, the purchaser of the share is investing $29.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.22%.

More news about Fastenal Company.

9. LivaNova PLC (LIVN) – Dividend Yield: 2.34%

LivaNova PLC’s last close was $49.41, 17.46% below its 52-week high of $59.86. Intraday change was 0.9%.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

Earnings Per Share

As for profitability, LivaNova PLC has a trailing twelve months EPS of $-1.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.7%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 2.34%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 10.3% and 1.2%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

LivaNova PLC’s EBITDA is 89.84.

More news about LivaNova PLC.

10. A10 Networks (ATEN) – Dividend Yield: 2.17%

A10 Networks’s last close was $11.07, 44.06% below its 52-week high of $19.79. Intraday change was -0.95%.

A10 Networks, Inc. provides networking solutions in the United States, Japan, other Asia Pacific, and EMEA countries. The company offers Thunder Application Delivery Controller (ADC) that provides advanced server load balancing; Lightning ADC, a cloud-native software-as-a-service platform to boost the delivery and security of applications and micro services; and Thunder Carrier Grade Networking product, which offers standards-compliant address and protocol translation services for service provider networks. It also provides Thunder Threat Protection System (TPS) for the protection of networks and server resources against massive distributed denial of service attacks; Thunder Secure Sockets Layer (SSL) Insight solution that decrypts SSL-encrypted traffic and forwards it to a third-party security device for deep packet inspection; and Thunder Convergent Firewall, which addresses various critical security capabilities in one package by consolidating various security and networking functions in a single appliance. In addition, the company offers intelligent management and automation tools comprising harmony controller that provides intelligent management, automation, and analytics for secure application delivery in multi-cloud environment; and aGalaxy TPS, a multi-device network management solution. The company delivers its solutions on optimized hardware appliances, bare metal software, containerized software, virtual appliances, and cloud-native software. It serves cloud providers, service providers, government organizations, and enterprises in the telecommunications, technology, industrial, retail, government, financial, gaming, and education industries. The company markets its products through sales organizations, as well as distribution channel partners, including distributors, value added resellers, and system integrators. A10 Networks, Inc. was incorporated in 2004 and is headquartered in San Jose, California.

Earnings Per Share

As for profitability, A10 Networks has a trailing twelve months EPS of $0.6.

PE Ratio

A10 Networks has a trailing twelve months price to earnings ratio of 18.27. Meaning, the purchaser of the share is investing $18.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.59%.

Volume

Today’s last reported volume for A10 Networks is 268731 which is 62.92% below its average volume of 724739.

More news about A10 Networks.